Denali Therapeutics
DNLI
#4443
Rank
โ‚น150.35 B
Marketcap
โ‚น1,035
Share price
-10.96%
Change (1 day)
-39.59%
Change (1 year)

Revenue for Denali Therapeutics (DNLI)

Revenue in 2024 (TTM): N/A

a decrease over the revenue in the year 2023 that were of โ‚น27.51 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Denali Therapeutics from 2017 to 2024

Annual revenue

Year Revenue Change
2024 N/A-100%
2023 โ‚น27.51 B206.58%
2022 โ‚น8.97 B147.81%
2021 โ‚น3.62 B-85.25%
2020 โ‚น24.54 B1190.35%
2019 โ‚น1.90 B-78.93%
2018 โ‚น9.03 B
2017 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น51.76 BN/A Jersey
โ‚น58.34 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น10.43 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.86 BN/A๐Ÿ‡ฌ๐Ÿ‡ง UK